The U.S. cleared Johnson & Johnson's single-dose COVID-19 shot on Saturday, adding a third vaccine option to the race against the virus. View original article here Source

The latest:The first big real-world study of the Pfizer-BioNTech vaccine to be independently reviewed shows the shot is highly effective at preventing COVID-19, in a potentially landmark moment for countries desperate to end lockdowns and reopen economies. Up until now,...

The World Health Organization's global vaccine-sharing scheme COVAX delivered its first COVID-19 shots on Wednesday, as the race to get doses to the world's poorest people and tame the pandemic accelerates.A flight carrying 600,000 doses of the AstraZeneca-Oxford vaccine produced...

Johnson & Johnson's one-shot COVID-19 vaccine appeared safe and effective in trials, U.S. Food and Drug Administration (FDA) staff said in documents published on Wednesday, paving the way for its approval for emergency use.The FDA's panel of independent experts is...

The latest:Drug maker Johnson & Johnson says it will be able to provide 20 million doses of its single-shot COVID-19 vaccine to the U.S. government by the end of March, assuming it gets the green light from federal regulators. J&J disclosed...

The latest:The United States on Monday crossed the staggering milestone of 500,000 COVID-19 deaths just over a year since the coronavirus pandemic claimed its first known U.S. victim in Santa Clara County, Calif. In a proclamation honouring the dead, U.S....

The latest: Tam stresses need for Canadians to maintain precautions as variant cases mount. More schools close in Quebec over coronavirus variant concerns. Students, staff at 5 B.C. public schools test positive for variant. Canada's new air travel rules go into...

For the last year, stories about hard-hit American communities clobbered by COVID-19 served as a cautionary tale. Its worst-hit states like North Dakota, South Dakota, and Arizona evoked a mixture of pity and horror at an out-of-control pandemic.The months of October...

The latest:Pfizer and BioNTech announced Thursday that a global clinical trial to evaluate their COVID-19 vaccine in pregnant women has begun.  The trial will include 4,000 women from countries around the world, including Canada, who will be vaccinated between their 24th and 34th week of...